1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23813
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIm, S. A.en
dc.contributor.authorGomez-Manzano, C.en
dc.contributor.authorFueyo, J.en
dc.contributor.authorLiu, T. J.en
dc.contributor.authorKe, L. D.en
dc.contributor.authorKim, J. S.en
dc.contributor.authorLee, H. Y.en
dc.contributor.authorSteck, P. A.en
dc.contributor.authorKyritsis, A. P.en
dc.contributor.authorYung, W. K.en
dc.date.accessioned2015-11-24T19:36:08Z-
dc.date.available2015-11-24T19:36:08Z-
dc.identifier.issn0008-5472-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23813-
dc.rightsDefault Licence-
dc.subjectAdenoviridae/geneticsen
dc.subjectAnimalsen
dc.subjectDNA, Antisense/*pharmacologyen
dc.subjectDown-Regulationen
dc.subjectEndothelial Growth Factors/*geneticsen
dc.subject*Gene Therapyen
dc.subjectGlioma/blood supply/*therapyen
dc.subjectHumansen
dc.subjectLymphokines/*geneticsen
dc.subjectMiceen
dc.subjectMice, Nudeen
dc.subjectNeovascularization, Pathologic/*therapyen
dc.subjectRNA, Messenger/analysisen
dc.subjectTumor Cells, Cultureden
dc.subjectVascular Endothelial Growth Factor Aen
dc.subjectVascular Endothelial Growth Factorsen
dc.titleAntiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivoen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/10029081-
heal.identifier.secondaryhttp://cancerres.aacrjournals.org/content/59/4/895.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1999-
heal.abstractPresently, there is no effective treatment for glioblastoma, the most malignant and common brain tumor. Angiogenic factors are potentially optimal targets for therapeutic strategies because they are essential for tumor growth and progression. In this study, we sought a strategy for efficiently delivering an antisense cDNA molecule of the vascular endothelial growth factor (VEGF) to glioma cells. The recombinant adenoviral vector Ad5CMV-alphaVEGF carried the coding sequence of wild-type VEGF165 cDNA in an antisense orientation. Infection of U-87 MG malignant glioma cells with the Ad5CMV-alphaVEGF resulted in reduction of the level of the endogenous VEGF mRNA and drastically decreased the production of the targeted secretory form of the VEGF protein. Treatment of s.c. human glioma tumors established in nude mice with intralesional injection of Ad5CMV-alphaVEGF inhibited tumor growth. Taken together, these findings indicate that the efficient down-regulation of the VEGF produced by tumoral cells using antisense strategies has an antitumor effect in vivo. This is the first time that an adenoviral vector is used to transfer antisense VEGF sequence into glioma cells in an animal model, and our results suggest that this system may have clinical and therapeutic utility.en
heal.journalNameCancer Resen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Im-1999-Antiangiogenesis tre.pdf678.09 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons